OMND — Optimind Pharma Balance Sheet
0.000.00%
- CA$1.10m
- CA$1.12m
- CA$0.12m
Annual balance sheet for Optimind Pharma, fiscal year end - February 29th, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.01 | 0.007 | 0.001 | 0.552 | 0.029 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.116 | 0.159 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.011 | 0.011 | 0.022 | 0.668 | 0.188 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | 0.095 | 0 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 0.011 | 0.011 | 0.022 | 1.35 | 0.238 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.06 | 0.088 | 0.188 | 0.625 | 0.367 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 1.06 | 0.088 | 0.188 | 0.715 | 0.367 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.05 | -0.077 | -0.166 | 0.64 | -0.129 |
Total Liabilities & Shareholders' Equity | 0.011 | 0.011 | 0.022 | 1.35 | 0.238 |
Total Common Shares Outstanding |